Ginsenosides Rg1 and CK Control Temozolomide Resistance in Glioblastoma Cells by Modulating Cholesterol Efflux and Lipid Raft Distribution.

Runze Qiu Jingjing Zhang Chun Ge Yue Zhong Suo Liu Qingquan Li XiaoMing Dai Hongwei Fan Yingbin Li

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

Ginsenosides Rg1 and CK controlled temozolomide resistance in glioblastoma cells by regulating cholesterol metabolism, which are potential synergists for temozolomide therapy.

Keyphrases

stem cells
induced apoptosis
cell cycle arrest
newly diagnosed
signaling pathway
low density lipoprotein